Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial of the Use of Intraperitoneal Local Anaesthetic

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* All they patients undergoing laparoscopic cholecystectomy will be included.~Exclusion Criteria:~* Patients with local anaesthetic allergy, patients on chronic opiate medication or those with neurological diseases that make pain evaluation unreliable will be excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Control (Type: SHAM_COMPARATOR): No intraperitoneal therapeutics (No nebulised Bupivacaine)
- IP Aerosolized Normal Saline (Type: PLACEBO_COMPARATOR): Intraperitoneal nebulised 10mls. Normal Saline (No nebulised Bupivacaine)
- Nebulised Bupivacaine intraperitoneally (Type: EXPERIMENTAL): Intraperitoneal Nebulised 10mls. Bupivacaione (Marcaine)
- Injected Bupivacaine intraperitoneally (Type: ACTIVE_COMPARATOR): Intraperitoeal Injected 10 mls.Bupivacaine (Marcaine) (No nebulised Bupivacaine)

Based on this trial design, predict the completion outcome and termination type (if applicable).